These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12446693)

  • 1. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation.
    Itoh F; Itoh S; Carvalho RL; Adachi T; Ema M; Goumans MJ; Larsson J; Karlsson S; Takahashi S; Mummery CL; Dijke PT; Kato M
    Lab Invest; 2009 Jul; 89(7):800-10. PubMed ID: 19398960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses.
    Yu L; Hébert MC; Zhang YE
    EMBO J; 2002 Jul; 21(14):3749-59. PubMed ID: 12110587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of specificity in TGF-beta signal transduction.
    Chen YG; Hata A; Lo RS; Wotton D; Shi Y; Pavletich N; Massagué J
    Genes Dev; 1998 Jul; 12(14):2144-52. PubMed ID: 9679059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
    Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
    Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a functional binding site for activin on the type I receptor ALK4.
    Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
    J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells.
    Kaivo-Oja N; Mottershead DG; Mazerbourg S; Myllymaa S; Duprat S; Gilchrist RB; Groome NP; Hsueh AJ; Ritvos O
    J Clin Endocrinol Metab; 2005 Jan; 90(1):271-8. PubMed ID: 15483083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional conservation of Schistosoma mansoni Smads in TGF-beta signaling.
    Beall MJ; McGonigle S; Pearce EJ
    Mol Biochem Parasitol; 2000 Nov; 111(1):131-42. PubMed ID: 11087923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
    Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
    J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.